KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Cash (2016 - 2025)

Historic Change in Cash for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Amgen's Change in Cash rose 58862.07% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $434.0 million, marking a year-over-year increase of 10168.67%. This contributed to the annual value of $1.0 billion for FY2024, which is 6895.93% down from last year.
  • Per Amgen's latest filing, its Change in Cash stood at $1.4 billion for Q3 2025, which was up 58862.07% from -$782.0 million recorded in Q2 2025.
  • Over the past 5 years, Amgen's Change in Cash peaked at $23.9 billion during Q1 2023, and registered a low of -$23.8 billion during Q4 2023.
  • In the last 5 years, Amgen's Change in Cash had a median value of -$290.0 million in 2024 and averaged $167.3 million.
  • Per our database at Business Quant, Amgen's Change in Cash soared by 930517.24% in 2021 and then plummeted by 117052.86% in 2023.
  • Quarter analysis of 5 years shows Amgen's Change in Cash stood at -$4.0 billion in 2021, then surged by 52.94% to -$1.9 billion in 2022, then tumbled by 1170.53% to -$23.8 billion in 2023, then skyrocketed by 112.45% to $3.0 billion in 2024, then tumbled by 52.16% to $1.4 billion in 2025.
  • Its Change in Cash was $1.4 billion in Q3 2025, compared to -$782.0 million in Q2 2025 and -$3.2 billion in Q1 2025.